Global Financial Private Client, LLC Crispr Therapeutics Ag Transaction History
Global Financial Private Client, LLC
- $257 Billion
- Q3 2024
A detailed history of Global Financial Private Client, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Global Financial Private Client, LLC holds 23 shares of CRSP stock, worth $952. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23
Previous 23
-0.0%
Holding current value
$952
Previous $1.24 Million
12.96%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CRSP
# of Institutions
490Shares Held
58MCall Options Held
1.1MPut Options Held
1.9M-
Capital International Investors Los Angeles, CA7.93MShares$328 Million0.07% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$311 Million3.35% of portfolio
-
State Street Corp Boston, MA2.99MShares$124 Million0.01% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.97MShares$123 Million0.1% of portfolio
-
Nikko Asset Management Americas, Inc.2.97MShares$123 Million1.61% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.23B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....